Status:
UNKNOWN
Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU
Lead Sponsor:
Ain Shams University
Conditions:
Hypophosphatemia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The current study aimed to determine the incidence of hypophosphatemia (HP) among severe sepsis/septic shock patients admitted to ICU and its impact on morbidity and mortality rates of these patients,...
Detailed Description
The study will include all patients admitted to ICU with or developing severe sepsis or septic shock within 24-hr after admission to ICU. Patients will be categorized according to at-admission inorgan...
Eligibility Criteria
Inclusion
- patients with severe sepsis and/or septic shock within 24 hours of admission to ICU
Exclusion
- children and adulthoods younger than 18 years
- pregnancy
- severe hemorrhagic shock
- maintenance on immunosuppressant therapy for any indication
- patients who are expected to die within the first 24 hours after admission
Key Trial Info
Start Date :
September 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04519762
Start Date
September 15 2020
End Date
December 15 2020
Last Update
August 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.